酪蛋白激酶2催化亚单位对雄激素受体信号转运表达的参与作用  被引量:1

Both CK2 catalytic subunits involves in androgen receptor signaling in prostate cancer cells

在线阅读下载全文

作  者:尧凯[1] 高晓燕[2] 黄必军[2] 李再尚[1] 周芳坚[1] 李本义 韩辉[1] 

机构地区:[1]中山大学肿瘤防治中心泌尿外科,广州510060 [2]华南肿瘤学国家重点实验室 [3]Department of Urology, The University of Kansas Medical Center, Kansas City, USA

出  处:《中华医学杂志》2013年第42期3360-3363,共4页National Medical Journal of China

基  金:国家自然科学基金(81302224)

摘  要:目的 探讨酪蛋白激酶2(CK2)催化亚单位是否都参与前列腺癌细胞雄激素受体信号转运表达.方法 CK2选择性抑制剂四溴肉桂酸(TBCA)和基因特异性小干扰RNA(siRNA)应用到多种前列腺癌细胞株进行检测,探讨CK2不同催化亚单位在雄激素受体(AR)信号传导的作用.萤光素酶基因报道分析检测雄激素受体反式激活,免疫荧光方法检测AR核定位以及定量聚合酶链反应(PCR)检测AR介导的基因表达.结果 TBCA阻断AR核转位和基因表达(P〈0.01).雄激素反应元件荧光素酶基因检测结果显示CK2α和CK2α'siRNA都显著减弱R1881(人工合成的雄性激素) 刺激引发的前列腺癌细胞活性(38.5与31.4),2种CK2催化亚单位都参与雄激素刺激的核转位和AR介导的基因表达(P〈0.05).结论 CK2亚单位CK2α和CK2α'都参与了雄激素受体信号转运表达.Objective To explore the roles of different casein kinase 2 (CK2) catalytic subunits in androgen receptor (AR) signaling in prostate cancer cell lines. Methods Prostate cancer cell lines were maintained. Immunofluorescent staining was performed to determine AR nuclear translocation in PC-3/AR cells with R1881 pretreatment and luciferase gene reporter assay used to determine AR transactivation in LNCaP cells. And reverse transcription-polymerase chain reaction (RT-PCR) was employed to evaluate the mRNA level of prostate-specific antigen ( PSA ). Results R1881-induced AR nuclear localization was reduced significantly (P 〈0.01 ). R1881-stimulated ARE-LUC reporter activity in LNCaP cells decreased with reduced level of PSA mRNA, an AR endogenous target (P 〈 0. 05 ). To confirm the target specificity, the gene-specific siRNAs were used for both CK2ct and CK2α' subunits. The results of ARE-LUC assay (38. 5 vs 31.4) suggested that both CK2 catalytic subunits were involved in androgen-stimulated AR nuclear translocation and AR-mediated gene expression in prostate cancer cells. Conclusion Both CK2 catalytic subunits are involved in androgen receptor signaling of prostate cancer cells.

关 键 词:酪蛋白激酶2 前列腺肿瘤 雄激素受体 四溴肉桂酸 

分 类 号:R737.25[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象